Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathologyInge M.W. Verberk, Charlotte E. Teunissen, Elisabeth H. Thijssen et al.|Alzheimer s Research & Therapy|2020Cited by 274
ATN classification and clinical progression in subjective cognitive declineJarith L. Ebenau, Wiesje M. van der Flier, Tessa Timmers et al.|Neurology|2020Cited by 200
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Pedro Rosa‐Neto, Thomas K. Karikari et al.|Nature Reviews Neurology|2024Cited by 171